Correlation Between Herantis Pharma and Metsa Board

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Herantis Pharma and Metsa Board at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Herantis Pharma and Metsa Board into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Herantis Pharma Oyj and Metsa Board Oyj, you can compare the effects of market volatilities on Herantis Pharma and Metsa Board and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Herantis Pharma with a short position of Metsa Board. Check out your portfolio center. Please also check ongoing floating volatility patterns of Herantis Pharma and Metsa Board.

Diversification Opportunities for Herantis Pharma and Metsa Board

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Herantis and Metsa is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Herantis Pharma Oyj and Metsa Board Oyj in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Metsa Board Oyj and Herantis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Herantis Pharma Oyj are associated (or correlated) with Metsa Board. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Metsa Board Oyj has no effect on the direction of Herantis Pharma i.e., Herantis Pharma and Metsa Board go up and down completely randomly.

Pair Corralation between Herantis Pharma and Metsa Board

Assuming the 90 days trading horizon Herantis Pharma Oyj is expected to generate 1.57 times more return on investment than Metsa Board. However, Herantis Pharma is 1.57 times more volatile than Metsa Board Oyj. It trades about -0.16 of its potential returns per unit of risk. Metsa Board Oyj is currently generating about -0.26 per unit of risk. If you would invest  143.00  in Herantis Pharma Oyj on September 2, 2024 and sell it today you would lose (15.00) from holding Herantis Pharma Oyj or give up 10.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Herantis Pharma Oyj  vs.  Metsa Board Oyj

 Performance 
       Timeline  
Herantis Pharma Oyj 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Herantis Pharma Oyj has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's technical indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Metsa Board Oyj 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Metsa Board Oyj has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Herantis Pharma and Metsa Board Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Herantis Pharma and Metsa Board

The main advantage of trading using opposite Herantis Pharma and Metsa Board positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Herantis Pharma position performs unexpectedly, Metsa Board can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Metsa Board will offset losses from the drop in Metsa Board's long position.
The idea behind Herantis Pharma Oyj and Metsa Board Oyj pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data